• COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. • Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. • Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.